WHOCC
Postal address:
WHO Collaborating Centre for Drug Statistics Methodology
Norwegian Institute of Public Health
Postboks 222 Sk°yen
0213 Oslo
Norway

Visiting/delivery address:
Sandakerveien 24C
Bygg C
0473 Oslo
Norway

Tel:  +47 21 07 81 60
E-mail:
 
Copyright/Disclaimer

Alterations in ATC/DDD

Lists of ATC/DDD alterations decided at the latest meeting of the WHO International Working Group for Drug Statistics Methodology. Comments or objections to the ATC/DDD alterations should be forwarded to the WHO Collaborating Centre for Drug Statistics Methodology within the deadline. If no objections are received, the alterations will be considered final and included in the ATC/DDD Index. The year of implementation in the ATC/DDD Index is given in the list. 

Please note that all ATC and DDD alterations are valid and implemented annually.

Change of DDDs

ATC codeLevel namePrevious DDDNew DDDDeadline for objection to temporary alterations Implementation in ATC/DDD index
A10BJ02liraglutide1.2 mg P1.5 mg P01.02.20192020

Change of ATC level name

Previous nameNew ATC level nameATC codeDeadline for objection to temporary alterations Implementation in ATC/DDD index
lactobacillus fermentumlactobacillusG01AX1401.02.20192020
microspheres of human albuminperflutren, human albumin microspheresV08DA0101.02.20192020
microspheres of phospholipidsperflutren, phospholipid microspheresV08DA0401.02.20192020
perflubutane polymer microspheresperflubutane, phospholipid microspheresV08DA0601.02.20192020
sulfur hexafluoridesulfur hexafluoride, phospholipid microspheres V08DA0501.02.20192020

Change in ATC codes

INN/generic namePrevious ATC codeNew ATC codeDeadline for objection to temporary alterations Implementation in ATC/DDD index
No alterations.

Last updated: 2018-11-21